Compendia for coverage of off-label uses of drugs and biologics in an anticancer chemotherapeutic regimen
Abernethy AP, Hammond JM, Hubbard ML, Patwardhan MB, Orlando LA, McCrory DC, Balk E, Raman G, Chew P, Kupelnick B, Lau J
Record ID 32007000605
English
Authors' objectives:
The topic of this assessment is the evaluation of drug compendia for the purpose of informing the Centers for Medicare & Medicaid Services (CMS) on decisions about coverage of off-label uses of drugs and biologics in anticancer treatment.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.cms.gov/mcd/viewtechassess.asp?from2=viewtechassess.asp&where=index&tid=46&
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Antineoplastic Agents
- Drug Labeling
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.